Absence of Fas-L aggravates renal injury in acute Trypanosoma cruzi infection

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 8, 2009, Pages 1063-1071

  de Oliveira, Gabriel Melo ^a   Masuda, Masako Oya ^b   Rocha, Nazaré N ^c   Schor, Nestor ^d   Hooper, Cléber S ^e   de Araújo Jorge, Tânia C ^a   Henriques Pons, Andréa ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e Centro de Criação de Animais de Laboratório Fiocruz   (Brazil)

Author keywords

Acute kidney injury; Fas l; Myocarditis; Trypanosoma cruzi

Indexed keywords

MUS; TRYPANOSOMA CRUZI;

EID: 72449181719     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/s0074-02762009000800002     Document Type: Article

References (48)

1. Andrade SG 1990. Influence of Trypanosoma cruzi strain on the pathogenesis of chronic myocardiopathy in mice. Mem Inst Oswaldo Cruz 85: 17-27.
2. Andrade ZA 1991. Pathogenesis of Chagas' disease. Res Immunol 142: 126-129.
3. Anning PB, Grocott-Mason RM, Lewis MJ 1997. Effects of sulphydryl and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart. Endothelium 5: 265-275.
4. Araujo FF, Gomes JA, Rocha MO, Williams-Blangero S, Pinheiro VM, Morato MJ, Correa-Oliveira R 2007. Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. Front Biosci 1: 2797-2806.
5. Araújo-Jorge TC 1989. The biology of Trypanosoma cruzi-macrophage interaction. Mem Inst Oswaldo Cruz 84: 441-462.
6. Araújo-Jorge TC 2000. Doença de Chagas: manual para experimentação animal, Editora Fiocruz/Instituto Oswaldo Cruz, Rio de Janeiro, 368 pp.
7. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J 2000. Accelerated development of IgG auto-antibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci USA 97: 1184-1189.
8. Bohle A, Muller GA, Wehrmann M, Mackensen-Haen S, Xiao JC 1996. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies and chronic interstitial nephritides. Kidney Int 54 (Suppl.): S2-9.
9. Boneventre JV, Zuka A 2004. Ischemic acute renal failure: an inflammatory disease? Kydney Int 1: 480-485.
10. Cines DB, Pollak ES, Buck CQ, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick J, Konkle BA, Stern DM 1988. Endothelial cells in physiology and pathophisiology of vascular disorders. Blood 2: 3527-3534.
11. Coura JR 2007. Chagas disease: what is known and what is needed-a background article. Mem Inst Oswaldo Cruz 102 (Suppl. I): 113-122.
12. Coura JR, Dias JCP 2009. Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery. Mem Inst Oswaldo Cruz 104 (Suppl. I): 31-40.
13. Danilczyk U, Penninger JM 2006. Angiotensin-converting enzyme II in the heart and the kidney. Circ Res 98: 463-471.
14. De Meis J, Mendes-da-Cruz DA, Farias de Oliveira DA, Correa-de- Santana E, Pinto-Mariz F, Cotta-de-Almeida V, Bonomo A, Savino W 2006. Atrophy of mesenteric lymph nodes in experimental Chagas' disease: differential role of Fas/Fas-L and TNFRI/TNF pathways. Microbes Infect 8: 221-231.
15. de Oliveira GM, Diniz RL, Batista W, Batista MM, Bani Correa C, de Araujo-Jorge TC, Henriques-Pons A 2007. Fas ligand-dependent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infection. Am J Pathol 171: 79-86.
16. Dias JP, Bastos C, Araújo E, Mascarenhas AV, Martins Netto E, Grassi F, Silva M, Tatto E, Mendonça J, Araújo RF, Shikanai-Yasuda MA, Aras R 2008. Acute Chagas disease outbreak associated with oral transmission. Rev Soc Bras Med Trop 41: 296-300.
17. dos Santos PV, Roffê E, Santiago HC, Torres RA, Marino AP, Paiva CN, Silva AA, Gazzinelli RT, Lannes-Vieira J 2001. Prevalence of CD8(+)alpha beta T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(low)LFA-1(high) VLA-4(high) activation phenotype and expression of IFN-gammainducible adhesion and chemoattractant molecules. Microbes Infect 3: 971-984.
18. Fox GJ, Cohen JB, Loew MF 1984. Laboratory animal medicine, Academic Press Inc, Harcout Brace Jovanovich Publishers, San Diego, 1265 pp.
19. Freire de Lima CG, Nascimento DO, Soares MB, Bozza PT, Castro- Faria-Neto HC, de Mello FG, DosReis GA, Lopes MF 2000. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403: 199-203.
20. Friedewald JJ, Rabb H 2004. Inflamatory cells in ischemic acute renal failure. Kydney Int 66: 486-491.
21. Gallagher AM, Yu H, Printz MP 1998. Bradykinin-induced reductions in collagen gene expression involve prostacyclin. Hypertension 32: 84-88.
22. Guillermo LV, Silva EM, Ribeiro-Gomes FL, De Meis J, Pereira WF, Yagita H, DosReis GA, Lopes MF 2007. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection. J Leukoc Biol 81: 942-951.
23. Henriques-Pons A, De Meis J, Cotta-De Almeida V, Savino W, Araújo-Jorge TC 2004. Fas and perforin are not required for thymus atrophy induced by Trypanosoma cruzi infection. Exp Parasitol 107: 1-4.
24. Henriques-Pons A, Oliveira GM, Paiva MM, Correa AF, Batista MM, Bisaggio RC, Liu CC, Cotta-de-Almeida V, Coutinho CM, Persechini PM, Araújo-Jorge TC 2002. Evidence for a perforinmediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection. Int J Exp Pathol 83: 67-79.
25. Higuchi M de L, Benvenuti LA, Martins Reis M, Metzger M 2003. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 60: 96-107.
26. Hoste EA, Kellun JA 2006. Acute kidney dysfunction and the critically ill. Minerva Anestesiol 7: 133-143.
27. Huber S, Shi C, Budd RC 2002. Gamma/delta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J Virol 76: 6487-6494.
28. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, Tschopp J 2000. The caspase-8 inhibitor FLIP promotes activation of NFkappaB and Erk signaling pathways. Curr Biol 10: 640-648.
29. Lambert C, Landau AM, Desbarats J 2003. Fas-beyond death: a regenerative role for Fas in the nervous system. Apoptosis 8: 551-562.
30. Leon JS, Wang K, Engman DM 2003. Captopril ameliorates myocarditis in acute experimental Chagas disease. Circulation 107: 2264-2269.
31. Linjnem PJ, Petrov VV 2003. Role of intracardiac renin-angiotensinaldosterone system in extracellular matrix remodeling. Methods Find Exp Clin Pharmacol 25: 541-564.
32. Lopes MF, Nunes MP, Henriques-Pons A, Giese N, Morse HC III Davidson WF, Araújo-Jorge TC, Dos Reis GA 1999. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response. Eur J Immunol 29: 81-89.
33. Martins GA, Petkova SB, Machado FS, Kitsis RN, Weiss LM, Wintner RM, Tanowitz HB, Silva JS 2001. Fas-FasL interaction modulates nitric oxide production in Trypanosoma cruzi-infected mice. Immunology 103: 122-129.
34. Martins GA, Vieira LQ, Cunha FQ, Silva JS 1999. Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect Immun 67: 3864-3871.
35. Mitchell GF, Jeron A, Koren G 1998. Measurement of heart rate and Q-T interval in the unscious mouse. Am J Physiol 274 (3 Pt 2): H747-751.
36. Moncayo A 2003. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 98: 577-591.
37. Nelson RW, Couto CG 1992. Essentials of small animal internal medicine, Mosby-Year Book Inc, New York, 32 pp.
38. Palazzuoli A, Gallotta M, Iovine F, Nuti R, Silverberg DS 2008. Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome. Int J Clin Pract 62: 281-286.
39. Schelling JR, Cleveland RP 1999. Involvement of Fas-dependent apoptosis in renal tubular epithelial cell deletion in chronic renal failure. Kidney Int 56: 1313-1316.
40. Seko Y, Kayagaki N, Seino K, Yagita H, Okumura K, Nagai R 2002. Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3. J Am Coll Cardiol 39: 1399-1403.
41. Silverberg DS, Wexler D, Blum M, Wollman Y, Iaina A 2003. The cardio-renal anemia syndrome: does it exist? Nephrol Dial Transplant 18 (Suppl. 8): 7-12.
42. Silverberg DS, Wexler D, Blum M, Wollman Y, Iaina A 2004. The association between congestive heart failure and chronic renal disease. Curr Opin Nephrol Hypertens 13: 163-170.
43. Silverberg DS, Wexler D, Blum M, Wollman Y, Iaina A, Sheps D, Keren G, Scwartz D 2005. Erythropoietin in heart failure. Semin Nephrol 25: 397-403.
44. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozakis S, Nakao K, Nagata S 1995. Expression of the Fas ligand in cells of T cell lineage. J Immunol 154: 3806-3813.
45. Thadhani R, Pascual M, Boneventre JV 1996. Acute renal failure. N Engl J Med 334: 1448-1460.
46. Thome M, Tschopp J 2001. Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol 1: 50-58.
47. WHO - World Health Organization 2004. [homepage on the internet] [up date 2004 May 2; cited 2006 June 19]. TDR summary report 2004-2005. Avaliable from http://www.who.int/tdr/publications/tdrnews/default.htm.
48. Yoshida N 2009. Molecular mechanisms of Trypanosoma cruzi infection by oral route. Mem Inst Oswaldo Cruz 104 (Suppl. 1): 101-107.